Technologies Available for Licensing
RECOMBINANT P. VIVAX MEROZOITE PROTEIN-1 P42 VACCINE
In this application is the expression and purification of a recombinant Plasmodium vivax (SalI) PvMSP-1 p42. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant PvMSP-1 p42 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
Docket:WRAIR 2001-37
Publication/Issued No.:7,150,875
Publication/Issue Date:2006-12-19
Categories: Method
More Detail:Visit USPTO.GOV
Lab:WRAIR
Inventor(s):LANAR